Skip to main content

Grygiel Nancy A.'s Form 4 filing

Amgen Inc (AMGN) · filed May 5, 2026

Accession no.
0000318154-26-000064
Filed
May 5, 2026
Trade date
May 2-4, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions. Open-market sales total $400.5K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Grygiel Nancy A.CIK 0001816414Officer (SVP & CCO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 2, 2026Common StockFTax withholdingDisposed−126$329.82−$41,557.328,362Direct
May 2, 2026Common StockFTax withholdingDisposed−116$329.82−$38,259.128,246Direct
May 4, 2026Common StockSSaleDisposed−1,237$323.73F1−$400,454.017,009Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported is an average price of $323.7272 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)